Anti-TNFRSF5/CD40 Antibody (Selicrelumab)
Catalog No.
F1478
Anti-TNFRSF5/CD40 Antibody (Selicrelumab)
Featured Products
Selicrelumab is a CD40 antibody agonist that can induce changes in the tumor microenvironment. Selicrelumab can be used in pancreatic cancer research and neoadjuvant tumor therapy research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.2 kDa
Dry ice
1622140-49-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RO-7009789, RG-7876
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P25942
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD40 His at 2 ug/mL can bind Anti-TNFRSF5/CD40 Antibody (Selicrelumab)
TNFRSF5 / CD40
Please avoid freeze-thaw cycles.